Literature DB >> 28084335

HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.

Blanca Gonzalez-Farre1, Daniel Martinez1, Monica Lopez-Guerra1, Marc Xipell2, Ester Monclus2, Jordina Rovira3, Felipe Garcia4, Armando Lopez-Guillermo3, Luis Colomo5, Elias Campo1, Antonio Martinez1.   

Abstract

Human herpesvirus 8 (HHV8)-associated lymphoid proliferations are uncommon and poorly characterized disorders mainly affecting immunosuppressed patients, especially with HIV infection. They encompass different diseases with overlapping features that complicate their classification. In addition, the role of HHV8 in reactive lymphoid hyperplasia is not well known. To analyze the clinicopathological spectrum of these lesions, we have reviewed 66 biopsies of 61 patients with HHV8 infection. All cases were also investigated for Epstein-Barr virus (EBV) and HIV infection. We identified 13 (20%) cases of HHV8-related reactive lymphoid hyperplasia, 2 (3%) HHV8 plasmablastic proliferations of the splenic red pulp, 28 (42%) multicentric Castleman disease, 6 (9%) germinotropic lymphoproliferative disorders, and 17 (26%) HHV8-related lymphomas. As expected, the pathologic subtype was predictive of overall survival (P<0.05). Forty-seven of our cases were HIV positive (77%). In addition to the classical presentation of the different entities, we identified novel and overlapping features. Reactive HHV8 proliferations were frequently associated with systemic symptoms but never progressed to overt HHV8-positive lymphoma. Two cases had a plasmablastic proliferation limited to spleen. Eight cases of multicentric Castleman disease had a previously unrecognized presentation shortly after the diagnosis of HIV infection, six cases had cavity effusions, and three showed plasmablast enriched proliferations. One germinotropic lymphoproliferative disorder was EBV negative and three occurred in HIV-positive patients, who had distinctive clinical and morphological features. Two of the HHV8-related lymphomas did not fulfill the criteria for previously recognized entities. All these findings expand the clinical and pathological spectrum of HHV8-related lymphoid proliferations, which is broader than current recognized.

Entities:  

Mesh:

Year:  2017        PMID: 28084335     DOI: 10.1038/modpathol.2016.233

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  31 in total

1.  Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.

Authors:  Eric A Engels; Stefania Pittaluga; Denise Whitby; Charles Rabkin; Yoshiyasu Aoki; Elaine S Jaffe; James J Goedert
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

2.  In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.

Authors:  Blanca Gonzalez-Farre; Jordina Rovira; Daniel Martinez; Alexandra Valera; Adriana Garcia-Herrera; Maria Angeles Marcos; Carla Sole; Gael Roue; Dolors Colomer; Elena Gonzalvo; Imma Ribera-Cortada; Monica Araya; Josep Lloreta; Luis Colomo; Elias Campo; Armando Lopez-Guillermo; Antonio Martinez
Journal:  Mod Pathol       Date:  2014-04-25       Impact factor: 7.842

Review 3.  Human herpes virus 8 in solid organ transplantation.

Authors:  Ella J Ariza-Heredia; Raymund R Razonable
Journal:  Transplantation       Date:  2011-10-27       Impact factor: 4.939

4.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

6.  Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype.

Authors:  J W Said; I P Shintaku; H Asou; S deVos; J Baker; G Hanson; E Cesarman; R Nador; H P Koeffler
Journal:  Arch Pathol Lab Med       Date:  1999-03       Impact factor: 5.534

7.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.

Authors:  N Dupin; T L Diss; P Kellam; M Tulliez; M Q Du; D Sicard; R A Weiss; P G Isaacson; C Boshoff
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

9.  Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell response.

Authors:  Hesham El-Daly; Mark Bower; Kikkeri N Naresh
Journal:  Eur J Haematol       Date:  2009-10-03       Impact factor: 2.997

Review 10.  Dendritic cells: key players in human herpesvirus 8 infection and pathogenesis.

Authors:  Diana M Campbell; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Microbiol       Date:  2014-08-28       Impact factor: 5.640

View more
  11 in total

1.  Epstein-Barr virus reactivation influences clonal evolution in human herpesvirus-8-related lymphoproliferative disorders.

Authors:  Massimo Granai; Mattia Facchetti; Virginia Mancini; Jacqueline Goedhals; Alicia Sherriff; Lucia Mundo; Cristiana Bellan; Teresa Amato; Ester Sorrentino; Marco Ungari; Martine Raphael; Lorenzo Leoncini; Fabio Facchetti; Stefano Lazzi
Journal:  Histopathology       Date:  2021-10-04       Impact factor: 7.778

Review 2.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

Review 3.  Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Authors:  Yasodha Natkunam; Dita Gratzinger; Amy Chadburn; John R Goodlad; John K C Chan; Jonathan Said; Elaine S Jaffe; Daphne de Jong
Journal:  Blood       Date:  2018-08-06       Impact factor: 22.113

Review 4.  KSHV/HHV8-mediated hematologic diseases.

Authors:  Ethel Cesarman; Amy Chadburn; Paul G Rubinstein
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

Review 5.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2017.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2017-07-22       Impact factor: 0.196

Review 6.  Human Herpesvirus 8 and Lymphoproliferative Disorders.

Authors:  Maria Luisa Calabrò; Ronit Sarid
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

Review 7.  Classic KSHV/HHV-8-positive Primary Effusion Lymphoma (PEL): A Systematic Review and Meta-Analysis of Case Reports.

Authors:  Ilaria Cozzi; Giovanni Rossi; Emma Rullo; Valeria Ascoli
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-03-01       Impact factor: 2.576

Review 8.  Virus-Driven Carcinogenesis.

Authors:  Yuichiro Hatano; Takayasu Ideta; Akihiro Hirata; Kayoko Hatano; Hiroyuki Tomita; Hideshi Okada; Masahito Shimizu; Takuji Tanaka; Akira Hara
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 9.  Human herpes virus 8-positive germinotropic lymphoproliferative disorder: first case diagnosed in the UK, literature review and discussion of treatment options.

Authors:  Ahmed Ghoneima; Joanna Cooke; Emily Shaw; Avi Agrawal
Journal:  BMJ Case Rep       Date:  2020-09-02

10.  HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders.

Authors:  Sandra Sanchez; Luis Veloza; Luojun Wang; Mónica López; Armando López-Guillermo; Marta Marginet; Antonio Martínez; Olga Balagué; Elias Campo
Journal:  Int J Hematol       Date:  2020-06-11       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.